Interestingly, the CD44+CD133+ and ΔCD44+CD133+ subpopulations of Caco-2 cells displayed similar sensitivity to Juglone, although tumor-initiating cells generally show resistance, or lower sensitivity, to chemotherapeutic drugs (Phi et al., 2018; Li et al., 2021). The gene discussed is PROM1; the disease is neoplasm.